November 2017
the ATI-50001 and ATI-50002 thread
ATI-50001 is another selective JAK inhibitor being developed by Aclaris Therapeutics.
Aclaris is developing and testing an oral and topical version called ATI-50002. The oral version is currently in…
Discussion
the ATI-50001 and ATI-50002 thread
2 Likes